These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 455093)

  • 21. Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties.
    Trugman JM; Pronsky CJ; Wooten GF
    Adv Neurol; 1990; 53():107-10. PubMed ID: 2146858
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lateralization of striatal dopamine (D2) receptors in normal rats.
    Schneider LH; Murphy RB; Coons EE
    Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kainic acid lesions decrease striatal dopamine receptors and 1,4-dihydropyridine sites.
    Skattebøl A; Hruska RE; Hawthorn M; Triggle DJ
    Neurosci Lett; 1988 Jun; 89(1):85-9. PubMed ID: 2456499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum.
    Leysen JE; Gommeren W; Laduron PM
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
    Suga M
    Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
    [No Abstract]   [Full Text] [Related]  

  • 30. Localization of [3H]N-propylnorapomorphine binding in mouse striatum.
    Severson JA; Randall PK
    Brain Res; 1983 Nov; 279(1-2):295-8. PubMed ID: 6416612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
    Baring MD; Walters JR; Eng N
    Brain Res; 1980 Jan; 181(1):214-8. PubMed ID: 7350957
    [No Abstract]   [Full Text] [Related]  

  • 32. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum.
    Gorissen H; Ilien B; Aerts G; Laduron P
    FEBS Lett; 1980 Nov; 121(1):133-8. PubMed ID: 6161839
    [No Abstract]   [Full Text] [Related]  

  • 35. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 36. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 39. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.
    Shimoyama M; Kito S; Itoga E; Kishida T; Nanba K
    Jpn J Pharmacol; 1982 Dec; 32(6):1157-66. PubMed ID: 6819376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors.
    De Deurwaerdère P; Spampinato U
    Trends Pharmacol Sci; 2001 Oct; 22(10):502-4. PubMed ID: 11583806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.